Seminars in Thoracic and Cardiovascular Surgery
Volume 21, Issue 2 , Pages 154-158, Summer 2009

Current Options for Systemic Therapy in Mesothelioma

  • David M. Jackman, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to David M. Jackman, MD, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115

Dana-Farber Cancer Institute, Boston, Massachusetts

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This work was supported by the Alice and Stephen D. Cutler Investigator Fund in Thoracic Oncology at Dana-Farber Cancer Institute.

 Dr. Jackman has served on an advisory board to Genentech and has received honoraria from Roche.

PII: S1043-0679(09)00074-4

doi:10.1053/j.semtcvs.2009.06.010

Seminars in Thoracic and Cardiovascular Surgery
Volume 21, Issue 2 , Pages 154-158, Summer 2009

Article Tools